BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23474197)

  • 1. GPR39 up-regulation after selective antidepressants.
    Młyniec K; Nowak G
    Neurochem Int; 2013 Jun; 62(7):936-9. PubMed ID: 23474197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice.
    Młyniec K; Nowak G
    Pharmacol Rep; 2015 Dec; 67(6):1135-40. PubMed ID: 26481532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists.
    Młyniec K; Gaweł M; Nowak G
    Behav Brain Res; 2015; 287():135-8. PubMed ID: 25827929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?
    Młyniec K; Singewald N; Holst B; Nowak G
    J Affect Disord; 2015 Mar; 174():89-100. PubMed ID: 25490458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice.
    Mlyniec K; Ostachowicz B; Krakowska A; Reczynski W; Opoka W; Nowak G
    J Physiol Pharmacol; 2014 Oct; 65(5):673-8. PubMed ID: 25371526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008.
    Starowicz G; Jarosz M; Frąckiewicz E; Grzechnik N; Ostachowicz B; Nowak G; Mlyniec K
    J Affect Disord; 2019 Feb; 245():325-334. PubMed ID: 30419533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the GPR39 receptor in zinc deficient-animal model of depression.
    Młyniec K; Budziszewska B; Reczyński W; Sowa-Kućma M; Nowak G
    Behav Brain Res; 2013 Feb; 238():30-5. PubMed ID: 23089648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal correlates underlying the role of the zinc sensing receptor (GPR39) in passive-coping behaviour.
    Sah A; Kharitonova M; Mlyniec K
    Neuropharmacology; 2021 Oct; 198():108752. PubMed ID: 34390690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of neuronal pH by the metabotropic Zn(2+)-sensing Gq-coupled receptor, mZnR/GPR39.
    Ganay T; Asraf H; Aizenman E; Bogdanovic M; Sekler I; Hershfinkel M
    J Neurochem; 2015 Dec; 135(5):897-907. PubMed ID: 26375174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims.
    Młyniec K; Doboszewska U; Szewczyk B; Sowa-Kućma M; Misztak P; Piekoszewski W; Trela F; Ostachowicz B; Nowak G
    Neuropharmacology; 2014 Apr; 79():290-7. PubMed ID: 24333148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist.
    Młyniec K; Starowicz G; Gaweł M; Frąckiewicz E; Nowak G
    J Affect Disord; 2016 Sep; 201():179-84. PubMed ID: 27235821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test.
    Wolak M; Siwek A; Szewczyk B; Poleszak E; Pilc A; Popik P; Nowak G
    Pharmacol Rep; 2013; 65(4):991-7. PubMed ID: 24145093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
    Nowak G; Pomierny-Chamioło L; Siwek A; Niedzielska E; Pomierny B; Pałucha-Poniewiera A; Pilc A
    Neuropharmacology; 2014 Sep; 84():46-51. PubMed ID: 24796254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
    Cadeddu R; Ibba M; Sadile A; Carboni E
    Psychopharmacology (Berl); 2014 May; 231(9):1925-33. PubMed ID: 24221827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the GPR39 zinc receptor following inhibition of monoaminergic neurotransmission and potentialization of glutamatergic neurotransmission.
    Młyniec K; Gaweł M; Librowski T; Reczyński W; Bystrowska B; Holst B
    Brain Res Bull; 2015 Jun; 115():23-9. PubMed ID: 25917396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.
    Popik P; Kozela E; Krawczyk M
    Br J Pharmacol; 2003 Jul; 139(6):1196-202. PubMed ID: 12871839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission.
    Starowicz G; Siodłak D; Nowak G; Mlyniec K
    Pharmacol Rep; 2023 Jun; 75(3):609-622. PubMed ID: 36997827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy.
    Khan MZ
    Biomed Pharmacother; 2016 Apr; 79():263-72. PubMed ID: 27044837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.
    Viana A; Rates S; Naudin B; Janin F; Costentin J; do Rego JC
    J Psychopharmacol; 2008 Aug; 22(6):681-90. PubMed ID: 18308787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.
    Chenu F; Dailly E; Bourin M
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):187-93. PubMed ID: 16757155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.